Search research articles
Contact Us
Filters
Showing results (311-320 of 501) with videos related to
Page
of 51
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 5, 2019
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
Benjamin Weide, Thomas Eigentler, Chiara Catania, et al.
Pigment Cell & Melanoma Research
|
August 20, 2010
Meeting report from the Third Global Workshop on Melanoma
Sanjiv S Agarwala, Alessandra di Pietro, Keith T Flaherty, et al.
Cancer Immunology, Immunotherapy : CII
|
October 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors
Johanna Winter, Max M Lenders, Maximilian Gassenmaier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 1, 2012
[Actinic keratoses]
Eggert Stockfleth, Dorothea Terhorst, Axel Hauschild, et al.
European Journal of Cancer Care
|
August 21, 2018
Fear of cancer progression in patients with stage IA malignant melanoma
Tobias Wagner, Matthias Augustin, Christine Blome, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Celeste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 23, 2024
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
Jean Jacques Grob, Thomas Jouary, Brigitte Dréno, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2006
[Brief guidelines: malignant melanoma of the skin]
Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Frontiers in Oncology
|
August 28, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and <i>BRAF V600</i> mutation
Julia Forschner, Julia Huynh, Christopher Schroeder, et al.
Page
of 51
Search research articles
Search
Showing results (311-320 of 501) with videos related to
Sort By:
Page
of 51
Cancer Immunology, Immunotherapy : CII
|
September 5, 2019
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
Benjamin Weide, Thomas Eigentler, Chiara Catania, et al.
Pigment Cell & Melanoma Research
|
August 20, 2010
Meeting report from the Third Global Workshop on Melanoma
Sanjiv S Agarwala, Alessandra di Pietro, Keith T Flaherty, et al.
Cancer Immunology, Immunotherapy : CII
|
October 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors
Johanna Winter, Max M Lenders, Maximilian Gassenmaier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 1, 2012
[Actinic keratoses]
Eggert Stockfleth, Dorothea Terhorst, Axel Hauschild, et al.
European Journal of Cancer Care
|
August 21, 2018
Fear of cancer progression in patients with stage IA malignant melanoma
Tobias Wagner, Matthias Augustin, Christine Blome, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Celeste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 23, 2024
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
Jean Jacques Grob, Thomas Jouary, Brigitte Dréno, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2006
[Brief guidelines: malignant melanoma of the skin]
Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Frontiers in Oncology
|
August 28, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and <i>BRAF V600</i> mutation
Julia Forschner, Julia Huynh, Christopher Schroeder, et al.
Page
of 51